CORPORATE GOVERNANCE

Unified Business No.

00651344

Equity Status

7871

Foreign Company Name as specified in the Charter

ELIXIRON IMMUNOTHERAPEUTICS CAYMAN LIMITED

Amount of Capital (NT$)

5,000,000,000

Total Paid-in Capital (NT$)

1,342,781,940

Share Value (NT$)

10

Equity Amount (Shares)

134,278,194

Name of Representative

HUNG-KAI CHEN

Date of Registration

2017/01/13